As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Real-time index price for TSX Preferred Share Index (TXPR), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer Inc.'s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too. Spreads on the company's ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...

Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...